Publicaciones en las que colabora con Camilo Silva Frojan (23)

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  3. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  4. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  4. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2022

  1. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

    International Journal of Molecular Sciences, Vol. 23, Núm. 16

  2. Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown

    Nutrients, Vol. 14, Núm. 13

  3. Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance

    Nutrients, Vol. 14, Núm. 20

  4. ‘Obesities’: Position statement on a complex disease entity with multifaceted drivers

    European Journal of Clinical Investigation, Vol. 52, Núm. 7

2021

  1. FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes

    Cellular and Molecular Immunology, Vol. 18, Núm. 10, pp. 2457-2459

  2. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum Leptin levels

    Nutrients, Vol. 13, Núm. 4

  3. Role of ANGPTL8 in NAFLD improvement after bariatric surgery in experimental and human obesity

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2019

  1. Discriminatory ability of anthropometric measurements of central fat distribution for prediction of post-prandial hyperglycaemia in patients with normal fasting glucose: The DICAMANO Study NCT03506581 NCT

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects

    Obesity, Vol. 26, Núm. 4, pp. 672-682

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

2015

  1. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI

    Obesity Surgery, Vol. 25, Núm. 9, pp. 1594-1603

2012

  1. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294